Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 19/20 | 0.71 |
| ▸ | CPB1 | P15086 | 7/20 | 0.71 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6917738 | 1.00 | CPB2 (0.71) | CPB2CPB1KDM4C | |
| Hydrochloric Acid SCHEMBL6481277 | 0.99 | CPB2 (0.70) | CPB2CPB1KDM4C | |
| Hydrochloric Acid SCHEMBL6482172 | 0.88 | CPB2 (0.56) | CPB2CPB1 | |
| SCHEMBL8365725 | 0.86 | CPB2 (0.55) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL6496193 | 0.85 | CPB2 (0.54) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL6485970 | 0.85 | CPB2 (0.67) | CPB2CPB1KDM4C | |
| Hydrochloric Acid SCHEMBL6484886 | 0.85 | CPB2 (0.67) | CPB2CPB1KDM4C | |
| SCHEMBL6248361 | 0.84 | CPB2 (0.74) | CPB2CPB1KDM4C | |
| SCHEMBL6493209 | 0.83 | CPB2 (1.00) | CPB2CPB1KDM4C | |
| Hydrochloric Acid SCHEMBL6484890 | 0.83 | CPB2 (0.73) | CPB2CPB1KDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6713496-B2 | 3-(imidazolyl)-2-alkoxypropanoic acids | PFIZER INC | 2004-03-30 | — | — | US | claimed |
| US-20030199522-A1 | 3-(Imidazolyl)-2-alkoxypropanoic acids | PFIZER INC. | 2003-10-23 | — | — | US | claimed |
| US-6958402-B2 | 3-(imidazolyl)-2-alkoxypropanoic acids | PFIZER, INC. (US) | 2005-10-25 | — | — | US | disclosed |
| US-20040254164-A1 | 3-(imidazolyl)-2-alkoxypropanoic acids | PFIZER INC. (US) | 2004-12-16 | — | — | US | disclosed |
| US-6713496-B2 | 3-(imidazolyl)-2-alkoxypropanoic acids | PFIZER INC | 2004-03-30 | — | — | US | disclosed |
| US-20030199522-A1 | 3-(Imidazolyl)-2-alkoxypropanoic acids | PFIZER INC. | 2003-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199522-A1 | 3-(Imidazolyl)-2-alkoxypropanoic acids | F2, FGB, F7 | CPB2 1594/4885CPB1 2274/4885KDM4C 3610/4885 |
| US-20040254164-A1 | 3-(imidazolyl)-2-alkoxypropanoic acids | F2, FGB, F7 | CPB2 1573/4885CPB1 2253/4885KDM4C 3760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.